| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |